PT effective with acceptable toxicity profile. »
05/06/24

Ramucirumab beyond progressive disease may be beneficial. »
05/08/24

Significant increase in dose constraint violations observed. »
06/25/24

Co-inhibition of genes could further sensitize AML cells to Ara-c. »
06/25/24

Depression three times more common among head and neck cancer patients. »
06/25/24

Surgery-alone strategy with close follow-up achieves excellent outcomes. »
07/04/24

Polyamine biosynthesis upregulated in vemurafenib-resistant cancer. »
07/04/24

Tumor suppressive role for Gα13 in breast cancer cells. »
07/04/24

Additional processing time may be useful strategy. »
07/04/24

Predictors of poorer outcome were CD4 count less than 200 cells/mm3 and lack of HAART use. »
07/03/24